BioSpace News Archive

Genetown

Stoke Therapeutics Announces $90 Million Series B Financing to Advance Novel Oligonucleotide Medicines

Lead candidate to treat the genetic cause of Dravet Syndrome expected to reach clinic by 2020

October 23, 2018
·
2 min read
Business

Aerie Pharmaceuticals Establishes GMP PRINT® Production Facility in an Expanded Global Headquarters

The Company now occupies more than 60,000 sq. ft. of laboratory and office space at the Durham, North Carolina, facility

October 23, 2018
·
8 min read
Policy

Boston Scientific Prevails in German Edwards Lifesciences Litigation

Court Rules Edwards Lifesciences’ Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany

October 23, 2018
·
4 min read
Job Trends

BD To Invest $200 Million In Nebraska Operations Creating 300 More Jobs

Brings Total Company Investment in Nebraska to $340 Million in Two Years

October 23, 2018
·
4 min read
Business

CROMSOURCE Appoints Director of Regulatory Services and Expands Regulatory Operations

CROMSOURCE announced today the appointment of its Regulatory Services Department Director, Mr. David R. Dills, and the expansion of its Regulatory Services portfolio.

October 23, 2018
·
2 min read
Business

Northwestern’s Dr. Lee Shulman Joins Anpac Bio Technical Advisory Board

Dr. Shulman’s extensive, award-winning research experience and reputation for identifying innovative solutions to fight disease prompted the Anpac Bio TAB invitation

October 23, 2018
·
2 min read
Business

Change to Essity’s Executive Management Team

Margareta Lehmann, President of Health and Medical Solutions and a member of Essity’s Executive Management Team, is stepping down from her position due to retirement.

October 23, 2018
·
1 min read
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Researchers in Toronto, Calgary and Vancouver use genetics to find more personalized treatment options for prostate cancer patients

October 23, 2018
·
4 min read
Deals

Clearlake Capital to Acquire symplr

New buy and build investment in leading healthcare governance, risk and compliance SaaS platform

October 23, 2018
·
3 min read
Policy

STEMCELL Submits Drug Master File for mTeSR™1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells

STEMCELL Technologies announced it has filed a Type II Drug Master File (DMF) to the Food and Drug Administration (FDA) for the Cellular Therapy Ancillary Material mTeSR™1 and has been issued DMF# 18339.

October 23, 2018
·
2 min read